ArticleCancer prevention research (Philadelphia, Pa.)2023

Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.

Parijatham S Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.